Formulation and Evaluation of Vinylpyrrolidone/Vinylacetate Copolymer Microspheres with Carbamazepine
- 1 January 2000
- journal article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 5 (3), 347-353
- https://doi.org/10.1081/pdt-100100550
Abstract
Vinylpyrrolidone/vinylacetate copolymer (VP/VAc) was used for the enhancement of dissolution rate of carbamazepine, an antiepileptic drug characterized by very low water solubility. Microspheres containing different drug-to-polymer ratios were prepared using a solvent-evaporation technique and their physical characterizations were carried out by differential scanning calorimetry, x-ray diffractometry, and scanning electron microscopy. Through the solubilization kinetics and dissolution rates studies, the in vitro drug availability of the microspheres was evaluated. These results showed that the dissolution of carbamazepine in gastrointestinal fluids from all of the prepared formulations was increased with respect to the drug itself. However, the best dissolution parameters were obtained from 1:10 w/w system because of the presence of the drug in amorphous form and its efficient encapsulation.Keywords
This publication has 6 references indexed in Scilit:
- Carbamazepine and Polyethylene Glycol Solid Dispersions: Preparation, in Vitro Dissolution, and CharacterizationDrug Development and Industrial Pharmacy, 1997
- Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with griseofulvinJournal of Microencapsulation, 1993
- Heat of Fusion Measurement of a Low Melting Polymorph of Carbamazepine That Undergoes Multiple-Phase Changes During Differential Scanning Calorimetry AnalysisJournal of Pharmaceutical Sciences, 1991
- Pharmacokinetics and dissolution of two crystalline forms of carbamazepineInternational Journal of Pharmaceutics, 1983
- Pharmacokinetics of carbamazepine in normal manClinical Pharmacology & Therapeutics, 1975
- Dissolution Phenomena of Organic Medicinals involving Simultaneous Phase ChangesCHEMICAL & PHARMACEUTICAL BULLETIN, 1969